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y-Thrombin stimulated release of PH]arachidonic acid (PH]AA) accompanied by a significant production of PAF and 
lyso-PAF by rabbit platelets. These responses, which reflect PL4 activation, were observed after a prolonged lag and 
to a lower extent when compared to those induced by a-thrombin which evoked a much higher elevation in intracellular 
calcium. This elevation together with PH]AA release were markedly reduced by EDTA. However, addition of ionophore 
A23187 enhanced the release of PH]AA by y-thrombin to the levels similar to those of a-thrombin. We conclude that 
y-thrombin is able to activate PL4 and suggest that calcium influx may be a limiting factor for this activation. 
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1. INTRODUCTION 
Platelets respond to agonists, such as thrombin, 
by initiating a cascade of events which leads to ac- 
tivation of PLA2 [ 1,2]. This enzyme hydrolyses the 
membrane phospholipids at the sn-2 position 
leading to a preferential release of arachidonic acid 
(AA) [3-51 which is then converted into active 
metabolites (prostaglandins, thromboxane, leuko- 
trienes.. ) by cycle-oxygenase and lipoxygenase [6]. 
Parallelly, the hydrolysis of phospholipids by 
PLA2 leads to the generation of lysophospholipids, 
especially lyso-PAF which is converted into PAF, a 
potent proinflammatory mediator [7]. It is, there- 
fore, clear that PLA2 plays a key role in the syn- 
thesis of a variety of proinflammatory mediators. 
It has been shown that PKC is involved in the 
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regulation of PLAz activity in various cell types 
[S-12], although the exact mechanism of this 
regulation remains unclear. We have proposed that 
lipocortin-like protein(s), whose anti-PLAz activity 
is modulated by PKC-induced phosphorylation, 
may be involved in the regulation of PLAz activity 
in rabbit platelets [13]. However, it has been 
recently shown that y-thrombin (a product of 
limited proteolysis of a-thrombin), even though in- 
ducing PKC activation, has no effect on PLAz ac- 
tivity in human platelets [141. This finding was used 
to suggest that PKC and/or lipocortin-like pro- 
tein(s) are not involved in the regulation of PLAz 
activity in human platelets. 
The results of the present study show that, in 
fact, y-thrombin, at concentrations known to ac- 
tivate PKC, induces a significant release of AA 
from rabbit platelets. A concomitant synthesis of 
PAF and lyso-PAF was observed in the same con- 
ditions. Although y-thrombin was less active than 
a-thrombin in inducing AA release, its effect was 
markedly potentiated by the simultaneous addition 
of calcium ionophore A23 187. Our results indicate 
that, contrarily to previous findings on human 
platelets, y-thrombin is capable to induce PLAz ac- 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 445 
Volume 255, number 2 FEBS LETTERS September 1989 
tivation in rabbit platelets. They suggest that the in- 
flux of extracellular calcium is a limiting factor for 
this activation. 
2. MATERIALS AND METHODS 
2.1. Materials 
Unlabelled AA, calcium ionophore A23187 and essentially 
fatty acid-free bovine serum albumin (BSA) were from Sigma 
(St. Louis, MO, USA). (Y- and y-thrombin were prepared in the 
Laboratoire d’Hemostase et de Thrombose (Facultt Xavier 
Bichat, Paris) as indicated below. Tritiated AA 
([5,6,8,9,11,12,14,15 ‘H]AA) (200 Ci/mmol) was from Amer- 
sham. 
2.2. Preparation of a- and y-thrombin 
Human LY- and y-thrombin were prepared according to 
published methods [15,16] as previously detailed 1171. Both 
forms of thrombin were 98 f 2% active as tested by active site 
titration with NPGB (p ‘-nitrophenyl p-guanidinobenzoate) 
[18]. Specific clotting activity was 3100 + 200 U/mg for LY- 
thrombin and less than 10 U/mg for y-thrombin. 
2.3. Preparation and labelling of platelets 
Whole blood was obtained from the central ear artery of adult 
New Zealand rabbits and anticoagulated with EDTA (5 mM). 
Platelets were then separated from blood and washed as 
previously described [19]. The platelet suspension (5 x lo8 
cells/ml) was in a calcium-free Tyrode’s buffer consisting of 
2.6 mM KCl, 3.6 mM MgCl2, 140 mM NaCl, 12 mM NaHCOs, 
10 mM Tris, 0.2 mM EGTA, 5.5 mM glucose, 2.5 mg/ml 
gelatin at pH 6.5. Cycle-oxygenase was inhibited by 10 min in- 
cubation with 500 pM aspirin before incubating platelets with 
0.2 &i/ml [‘H&AA. After 90 min incubation at 37”C, the 
platelets were washed twice to remove unincorporated radioac- 
tivity. The uptake of [‘HJAA by platelets was estimated at 
70-80% of the total added [3H]AA. The final suspension 
(5 x lo* cells per ml) was in a calcium-Tyrode’s buffer (pH 7.4) 
which consisted essentially of the same reagents as above except 
that EGTA was replaced by 1.72 mM CaCl2 and gelatin by 
2.5 mg/ml BSA. 
2.4. Measurement of AA releasse 
Aliquots (0.5 ml) of labelled platelets were incubated with cr- 
or y-thrombin at concentrations indicated in the legends of 
figures and stimulations carried out at 37°C in the absence or in 
the presence of 5 mM EDTA. In some experiments platelets 
were incubated with 200 nM of calcium ionophore A23187 im- 
mediately before the addition of thrombin. After the intervals 
indicated in the figures, the reactions were terminated by the ad- 
dition of 0.5 ml saline containing 5 mM EDTA and 10 mg/ml 
BSA (pH 7.4) and maintained at 4°C. Platelets were then 
removed by 2 min centrifugation at 12000 rpm. The radioac- 
tivity in the 100 ,ul of supernatant was then determined by liquid 
scintillation spectrophotometry. Lipids in the remaining super- 
natants (900 rl) were rapidly extracted according to the method 
of Bligh and Dyer [20]. The organic phases were carefully 
removed and brought to dryness under a stream of nitrogen and 
finally redissolved in 50 pl chloroform/methanol (2 : 1). Then, 
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extracts were subjected to thin-layer chromatography (TLC) on 
plastic silicagel plates using chloroform/methanol/acetic 
acid/water (65 : 43 : 1: 3) as the mobile phase to separate lipids. 
Authentic unlabelled AA was also spotted on the same plates as 
standard to confirm the identity of released [“H]AA. Lipids 
were visualized by iodine vapour and plates scraped off in order 
to measure their radioactivity by liquid scintillation spectro- 
photometry. 
2.5. Measurement of PAF and lyso-PAF synthesis 
Aliquots (1 ml) from unlabelled platelets were incubated with 
18 nM of (Y- or y-thrombin at 37°C. Then, the reactions were 
terminated at the times indicated, by the addition of 1 ml 
methanol and lipid extraction carried out as indicated above. 
Thereafter, lipids were separated on TLC using chloroform/ 
methanol/water (70: 35 : 7) as mobile phase. Areas containing 
PAF or lyso-PAF (located by referring to corresponding stand- 
ards) were scraped off, resuspended in 1 ml methanol/water 
(2: 1) and extracted as indicated above. The organic phases were 
then removed and brought to dryness under nitrogen. The assay 
of PAF and lyso-PAF was carried out as previously described 
[211. 
2.6. Measurement of cytosolic free calcium concentrations 
Washed platelets were incubated in calcium-free buffer with 
3 PM of Fura- AM at 37°C. Fura- was liberated from its 
methyl ester Fura- AM by cytosolic esterase inside the cell [22]. 
After 30 min, loaded platelets were centrifuged to remove ex- 
traneous Fura- AM and resuspended in calcium- and EDTA- 
free buffer. Calcium (1 mM) or EDTA (5 mM) were then added 
to platelets before their stimulation with agonists. Fluorescence 
changes were monitored in 2 ml platelet samples with a Jobin- 
Yvon (JY 3D) spectrophotometer. The intracellular calcium 
levels were calculated as previously described [22]. 
3. RESULTS AND DISCUSSION 
Stimulation of [3H]AA labelled platelets with CX- 
or y-thrombin led to a time-dependent release of 
[3H]AA in the medium (fig.1). While [3H]AA re- 
lease was rapidly observed with a-thrombin, a pro- 
longed lag phase was observed when using y- 
thrombin. Half-maximal responses were observed 
1 min and 3 min after platelet stimulation with LY- 
and y-thrombin, respectively. [3H]AA release in- 
creased rapidly to reach a maximum (8-10’70 of 
total incorporated radioactivity) after 5 min in- 
cubation with cy-thrombin. In the presence of y- 
thrombin, this release increased with a lower 
velocity and reached its maximum (5-69’0) after 
10 min stimulation. 
The concentration-response curve of t3H]AA re- 
lease was studied by increasing the concentration 
of thrombin from 5 to 50 nM. Fig.1 shows that 
[3H]AA release increased with the thrombin con- 
centration, y-thrombin being approximately two 
Volume 255, number 2 FEBS LETTERS September 1989 
0 alpha 
n gamma 
0 2 4 6 8 10 12 
Time (min) 
I 
f lo- 
E 
e 
s 
8- 
.o 
5 
6- 
YE 
r 
s 
4- 
c 
i 2- 
“8 
q alpha 
= gamma 
0 10 20 30 40 50 
Thrombin (nM) 
Fig.1. (Y- and y-thrombin-induced release of AA from rabbit 
platelets. Time course (upper panel) and concentration-re- 
sponse curve (lower panel). Rabbit platelets were pretreated 
with aspirin and labelled with 0.2 &i/ml [3H]AA as indicated 
in section 2. Aliquots (0.5 ml) of platelet suspensions were 
stimulated with 18 nM thrombin for the indicated times or with 
increasing concentrations of thrombin for 3 min at 37°C. The 
reactions were terminated by the addition of 0.5 ml of saline 
solution containing 10 mM EGTA and 10 mg/ml BSA. The re- 
lease of [3H]AA was then measured as detailed in section 2. The 
figures represent he release of [‘H]AA expressed as percent of 
total radioactivity incorporated in the cells and are the mean f 
SD of 3 separate xperiments. 
times less potent than cu-thrombin. Indeed, the 
EGO values were estimated at 9-10 and 18-20 nM, 
for LY- and y-thrombin, respectively. 
Using washed human platelets, Jandrot-Perrus 
et al. (manuscript in preparation) have observed 
that y-thrombin induced an increase of thrombox- 
ane Bz synthesis. The latter was detected after a 
prolonged delay and at a lower amount when com- 
pared to that induced by a-thrombin. Thus, it is 
clear that, although y-thrombin is a less potent ac- 
tivator than cu-thrombin, it is still effective in in- 
ducing PLAz activation. 
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Fig.2. Effects of cy- and y-thrombin on the production of PAF 
and lyso-PAF by rabbit platelets. 0.5 ml aliquots of unlabelled 
platelets were stimulated with 18 nM of (Y- or y-thrombin and 
the reactions terminated at the indicated times by the addition 
of 1 ml methanol. PAF and lyso-PAF were extracted and their 
amounts determined as indicated in section 2. The results show 
the production of PAF (upper panel) and lyso-PAF (lower 
panel) expressed in pmol/ml platelets and are representative of
2 separate xperiments. 
We have also investigated the effect of y- 
thrombin on the production of PAF and its im- 
mediate precursor lyso-PAF. Fig.2 shows that 
stimulation of platelets by y-thrombin led to a 
significant production of PAF and lyso-PAF. This 
was observed after a delay of 2-3 min, whereas in 
the presence of a-thrombin the production of PAF 
and lyso-PAF was detected after a short time of 
stimulation. The enhancement of lyso-PAF pro- 
duction is of particular interest since this com- 
pound directly reflects the activation of PLA2 [7]. 
On the other hand, we have investigated the ef- 
fect of extracellular calcium on the release of [3H]- 
AA induced by the two forms of thrombin. Fig.3 
shows that this release was completely blocked by 
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Fig.3. Effect of EDTA on thrombin-induced release of AA 
from rabbit platelets. 0.5 ml aliquots of [3H]AA prelabelled 
platelets were incubated with 5 mM EDTA or 50,ul saline, 
10 min before the addition of 18 nM thrombin. Stimulations 
were carried out for 3 min at 37°C and the release of [“HIAA 
measured as indicated above. 
the chelation of extracellular calcium by EDTA 
suggesting that the activation of PLA2 by thrombin 
is dependent on the influx of extracellular calcium 
rather than on the mobilization of intracellular 
calcium. Therefore, we have compared the effect 
of y- and cu-thrombin on the increase of cytosolic 
calcium concentration using Fura- loaded 
platelets. Fig.4 shows that both cy- and y-thrombin 
produced a dose-dependent increase of intra- 
cellular calcium concentration which was markedly 
reduced in the presence of EDTA. The responses 
induced by y-thrombin occurred at a lesser extent 
and with a lower velocity than those induced by LY- 
thrombin. For example, incubation of platelets 
with 12 nM of cu-thrombin led to an increase in in- 
tracellular calcium concentration reaching a value 
6 times higher than that induced by the same con- 
centration of y-thrombin (fig.4, left panel). Thus, 
we have postulated that the low potency of y- 
thrombin in inducing PLAz activation may be due 
to its limited capacity to induce calcium influx. To 
examine this hypothesis we have investigated the 
effect of calcium ionophore A23187 on the release 
of AA by thrombin-stimulated platelets in the 
presence of calcium. Our results show that A23 187 
(200 nM) potentiates the release of [3H]AA induc- 
ed by both forms of thrombin (fig.5). When used 
alone at the same concentration, A23187 had no 
significant effect on the release of [3H]AA (less 
than 1%). The synergistic effect of A23187 was 
more pronounced in the presence of y-thrombin. 
Indeed, A23187 reduced by 5 times the EC50 of y- 
thrombin-induced [‘H]AA release (EC50 = 20 and 
4 nM, in the absence and in the presence of 
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Fig.4. Changes in cytosolic calcium concentration in response to LY- and y-thrombin. 2 ml aliquots from Fura- loaded platelets (see 
section 2) were stimulated with LY- (0-T) or y-thrombin (7-T) at the concentrations indicated next to each trace and expressed in nM. 
Stimulations were carried out in the presence of 1 mM calcium (left panel) or 5 mM EDTA (right panel). The fluorescence calibration 
for intracellular calcium levels was calculated as previously described [22]. The intracellular calcium concentrations vary from a basal 
value of 100 nM (resting platelets) to 2550 nM in the presence of 30 nM cu-thrombin. The figure shows traces representative of 3 ex- 
periments. 
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Fig.5. Synergistic effect of calcium ionophore A23187 on 
thrombin-induced release of AA by platelets. 0.5 ml aliquots of 
[3H]AA prelabelled platelets were incubated with 200 nM 
A23187 or with its solvent dimethylsulfoxide (2 cl) as a control. 
(Y- or y-thrombin were immediately added to platelets at the in- 
dicated concentrations. The reactions were stopped after 3 min 
stimulation at 37°C and the release of [‘H]AA measured as in- 
dicated in section 2. The figures show the release of [“H&A by 
cr-thrombin (upper panel) and y-thrombin (lower panel) in the 
presence (+ ionophore) or in the absence (- ionophore) of 
calcium ionophore A23 187. 
A23187, respectively). However, in the case of a- 
thrombin, this value decreased only by 2.5 times 
(from 10 to 4 nM). 
Our results clearly show that y-thrombin, al- 
though less active than cu-thrombin, is capable of 
inducing PLA2 activation in rabbit platelets. How- 
ever, Crouch and Lapetina [14] have shown that y- 
thrombin, at a concentration which fully activated 
PKC, failed to induce [3H]AA release by human 
platelets. This observation was used to suggest hat 
PKC may not play a role in the regulation of PLAz 
activity. In fact, their results are probably ac- 
counted for by the lower sensitivity of human 
platelets to y-thrombin or to the relatively short 
time of incubation they used in their study. Indeed, 
in our conditions, the release of [3H]AA induced 
by y-thrombin was observed l-2 min later than 
that induced by cu-thrombin. We suggest hat the 
lower potency of y-thrombin to induce PLA2 ac- 
tivation may result from its limited capacity to in- 
duce extracellular calcium influx. This is supported 
by the finding that, in the presence of calcium iono- 
phore A23 187, y-thrombin became as active as CY- 
thrombin in inducing [‘H]AA release. 
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